Share chart Propanc Biopharma, Inc.
Extended chart
Simple chart
About Propanc Biopharma, Inc.
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. more detailsISIN | US74346N4043 |
---|---|
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.propanc.com |
Цена ао | 5.68 |
Change price per day: | 0% (9.98) |
---|---|
Change price per week: | +99.6% (5) |
Change price per month: | +47.85% (6.75) |
Change price per 3 month: | -43.45% (17.6471) |
Change price per half year: | -43.45% (17.6471) |
Change price per year: | +767 592.31% (0.0013) |
Change price per 3 year: | +83 066.67% (0.012) |
Change price per 5 year: | +23 109.3% (0.043) |
Change price per year to date: | -15.17% (11.7647) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. James Nathanielsz | Executive Chairman, CEO, CFO, Treasurer & Secretary | 430.28k | 1974 (51 year) |
Dr. Julian Norman Kenyon ChB, M.D., MB | Chief Scientific Officer, CTO & Director | 35.99k | 1948 (77 years) |
Prof. Klaus Kutz | Chief Medical Officer & Member of Scientific Advisory Board | 18.23k |
Address: Australia, Camberwell. VIC, 302. 6 Butler Street - open in Google maps, open in Yandex maps
Website: https://www.propanc.com
Website: https://www.propanc.com